Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: a randomized trial

Effect of Chlorogenic Acid on H2O2-Induced Dysfunction and Apoptosis in HUVECs

To investigate the protective effects and the possible molecular mechanisms of chlorogenic acid on H2O2-induced dysfunction and apoptosis in human umbilical vein endothelial cells (HUVECs). HUVECs were divided into three groups: H2O2groups (0, 5, 10, 20, 50mM), chlorogenic acid (100nmol/L) groups and atorvastatin (10μmol/L) groups. The eNOS mRNA expression was measured by RT-PCR. The content of NO in the supernatant was detected by the nitrate reductase assay. Cells activity was evaluated by the MTT assay. The level of reactive oxygen species (ROS) in cells was measured using H2DCF-DA as a fluorescence probe. Results demonstrated that H2O2caused a significant down-regulation of eNOS mRNA expression and decreased the secretion of NO in a dose-dependent manner compared with the control group. Furthermore, H2O2 induced cell apoptosis, increased ROS accumulation. Nevertheless, these effects of H2O2could be blocked by chlorogenic acid in chlorogenic acid pretreatment groups. CONCLUSION:chlorogenic acid can inhibite H2O2-induced dysfunction and apoptosis in HUVECs, which may be related to its effects on suppressing oxidative stress, up-regulating eNOS pathway. These results suggest the usefulness of chlorogenic acid particularly in the treatment of cardiovascular disease.

Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice

The increasing prevalence of the metabolic syndrome requires a greater need for therapeutic and prevention strategies. Higher coffee consumption is consistently associated with a lower risk of type 2 diabetes in population studies. Dietary polyphenols have been linked to benefits on several features of the metabolic syndrome. Chlorogenic acid (CGA), a major component of coffee, is one of the most consumed polyphenols in the diet. In our study, we conducted a controlled dietary intervention over 12 weeks in male mice. There were three dietary groups: (i) normal diet, (ii) high-fat diet, and (iii) high-fat diet + CGA. We assessed the effect of CGA at a physiologically obtainable dose (1 g/kg of diet) on high-fat-diet-induced obesity, glucose intolerance, insulin resistance, and also fatty acid oxidation and insulin signaling in C57BL/6 male mice. Supplementation of CGA in the high-fat diet did not reduce body weight compared to mice fed the high-fat diet alone (p = 0.32). CGA resulted in increased insulin resistance compared to mice fed a high-fat diet only (p < 0.05). CGA resulted in decreased phosphorylation of AMP-activated protein kinase (AMPK) (p < 0.001) and acetyl carboxylase β (ACCβ), a downstream target of AMPK (p < 0.05), in liver. The liver of mice fed a high-fat diet supplemented with CGA had a higher lipid content (p < 0.05) and more steatosis relative to mice fed a high-fat diet only, indicating impaired fatty acid oxidation. This study suggests that CGA supplementation in a high-fat diet does not protect against features of the metabolic syndrome in diet-induced obese mice.